Although data exist to suggest the overproduction of IL-1 in these diseases is associated with an increase in IL-1 mRNA expression (53), there is strong evidence to suggest that the proteasome is impaired in both Alzheimer and Parkinson disease (54, 55). Here, IL1B is linked to Parkinson disease.